IWKS — Health Sciences Share Price
Last Trade - 00:00Momentum
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | |||
| EPS Growth (f) | |||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | |||
| Price to Tang. Book | |||
| Price to Free Cashflow | |||
| Price to Sales | |||
| EV to EBITDA | |||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | |||
| Return on Equity | |||
| Operating Margin | |||
Financial Summary
| Year End 30th Jun | Unit | 2004 | 2005 | 2006 | 2007 | 2008 | 2009E | 2010E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 19.83 | 23.14 | 25 | 28.72 | 34.28 | n/a | n/a | 13.7% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | +37.54 | -50.31 | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Health trend(F-Score)
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Health Sciences Corporation, formerly AFP Imaging Corporation, is engaged in providing imaging solutions to dental health professionals. The Company's products include panoramic and three dimensional (3D) imaging, intraoral X-rays, digital sensors and dental imaging software. The Company's panoramic and 3D imaging product includes Panoura 18S, a two dimensional (2D) and 3D dental imaging system. The Company's intraoral X-rays include DC Intraoral X-ray, Intraskan DC; AC intraoral X-ray, Endos ACP, and mobile intraoral X-ray, mobile Intraskan. The Company's digital sensors include EVA Select digital sensors. The Company's dental imaging software includes EVAsoft Dental Image Management software.
Directors
- R Jones
- Donald Rabinovitch PRE (67)
- David Vozick CEO (73)
- Bryan Jaffe (51)
- Daniel Fields (64)
- Aida McKinney EVP (57)
- Roberto Molteni (63)
- Gary Jaggard (56)
- Last Annual
- June 30th, 2008
- Last Interim
- March 31st, 2009
- Incorporated
- September 20th, 1978
- Public Since
- October 14th, 1980
- No. of Shareholders
- 295
- No. of Employees
- 122
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 35,858
- Address
- 685 Dividend Dr Ste 250, PEACHTREE CITY, 30269-1964
- Web
- Phone
- +1 6789878579
- Auditors
- McGladrey & Pullen, LLP
Similar to IWKS
ADVANCED BIOMEDICAL TECHNOLOGIES ORD
Pink Sheets on Nasdaq
AKSYS ORD
Pink Sheets on Nasdaq
ALR TECHNOLOGIES ORD
Pink Sheets on Nasdaq
AVITAR ORD
Pink Sheets on Nasdaq
BIOLIFE SCIENCES ORD
Pink Sheets on Nasdaq
FAQ
As of Today at 19:56 UTC, shares in Health Sciences are trading at $0.50. This share price information is delayed by 15 minutes.
Shares in Health Sciences last closed at $0.50 and the price had moved by -49.99% over the past 365 days. In terms of relative price strength the Health Sciences share price has underperformed the S&P500 Index by -61.31% over the past year.
There is no consensus recommendation for this security.
Health Sciences does not currently pay a dividend.
Health Sciences does not currently pay a dividend.
Health Sciences does not currently pay a dividend.
To buy shares in Health Sciences you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.50, shares in Health Sciences had a market capitalisation of .
Here are the trading details for Health Sciences:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: IWKS
Based on an overall assessment of its quality, value and momentum Health Sciences is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Health Sciences. Over the past six months, its share price has underperformed the S&P500 Index by -74.93%.
As of the last closing price of $0.50, shares in Health Sciences were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We are not able to find PE ratio data for Health Sciences.
Health Sciences' management team is headed by:
- R Jones -
- Donald Rabinovitch - PRE
- David Vozick - CEO
- Bryan Jaffe -
- Daniel Fields -
- Aida McKinney - EVP
- Roberto Molteni -
- Gary Jaggard -
We do not have data on Health Sciences' shareholders